Pharmaceutical Business review

Reliant Technologies wins FDA approval for new Fraxel laser handpieces

According to the company, these handpieces expand the capabilities of the Fraxel re:pair laser system, providing physicians with a complete skin resurfacing and surgical treatment option.

As part of the Fraxel re:pair complete fractional ablative workstation, all three surgical handpieces can be used either alone or in combination with each other, without turning the system off to change handpieces.

Len DeBenedictis, chief technology officer of Reliant, said: “The Fraxel family of lasers offers the most advanced laser treatments in the market today, providing safe, precise and effective treatments for a range of skin conditions and skin types.

“The addition of the new handpieces for the Fraxel re:pair system furthers our market leading position and will allow physicians to provide superior ablative skin resurfacing with the option of performing minor surgical treatments as well.”